Examining the Trajectory of Ground Glass Nodule Patients in China: A Real-World Perspective

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background Lung cancer poses a major health burden in China, and ground-glass nodules (GGNs) are important early indicators of malignancy, with persistent or part-solid GGNs carrying particularly high cancer risk in Asian populations. This study aims to clarify the real-world patient journey in China following a GGN diagnosis to support improved management and outcomes. Methods Data were extracted from electronic medical records of three large tertiary hospitals with high cancer population in China. Adult patients (≥ 18 years) diagnosed with GGN for the first time between January 1, 2019, and December 31, 2019, were identified. The data collection period spanned from 1 January 2018 to 1 June 2023. Patient demographics, clinical characteristics, diagnostic methods, and treatment pathways were analyzed using descriptive statistics. Results Data from a total of 741 patients diagnosed with GGN were analyzed. The first visit in the medical records during the study period, 919 patients (10.9%) received lung biopsy (percutaneous or bronchoscopic), 2,192 patients (27.1%) directly underwent surgical removal of the lesion without lung biopsy, and 539 patients (6.7%) received lung biopsy and surgery during the index visit. A significant portion of patients (2,069, 25.5%) received only imaging examinations at their first visit, with computed tomography being used in 73.8% of the cases. Another 823 (10.2%) started cancer treatment at their first visit, while the remainder (N = 1,586, 19.9%) did not receive any of these procedures. The rate of a repeated biopsy during follow-up was 2.3% in the group of 886 patients who received only lung biopsy at their first visit. Conclusion This study provides valuable insights into the diagnostic practices and clinical pathways for LC patients in China. The findings underscore the need for optimized diagnostic strategies, enhanced patient education to improve early detection, and more effective treatment.

Article activity feed